YPL205C Antibody

What is the YPL205C protein and its known functions?

While the search results don't specifically mention YPL205C, we can discuss antibody targets generally. Antibodies are commonly developed against proteins with important cellular functions, such as the YPEL5 protein which localizes to the centrosome or mitotic spindle and is widely expressed in both adult and fetal tissue . When working with any antibody, understanding the target protein's subcellular localization, tissue distribution, and biological function is essential for experimental design. For instance, YPEL5 antibodies target a protein that belongs to a family of five yippee-like proteins involved in centrosome or mitotic spindle function .

What are the optimal storage conditions for antibodies like those targeting YPL205C?

Based on storage guidelines for similar research antibodies, most antibodies should be stored at -20°C for long-term stability (up to one year), while 4°C is suitable for short-term storage (up to three months). Repeated freeze-thaw cycles should be avoided as they can compromise antibody function. As demonstrated with the YPEL5 antibody, proper storage involves keeping the antibody in PBS containing 0.02% sodium azide . Always refer to specific manufacturer guidelines, as storage conditions may vary depending on antibody formulation and concentration.

What applications are antibodies against YPL205C typically used for?

While specific applications for YPL205C antibodies aren't mentioned in the search results, research antibodies like the YPEL5 antibody are commonly validated for multiple applications including Western blotting (WB), immunocytochemistry (ICC), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA) . When selecting an antibody for your research, confirm that it has been validated for your specific application. For example, the YPEL5 antibody described in the search results is reported to react with human and mouse samples across multiple applications .

How can researchers address observed discrepancies between predicted molecular weight and observed weight in Western blot experiments?

Discrepancies between calculated and observed molecular weights are common in antibody research. For example, the YPEL5 antibody detected a protein at 68 kDa despite a calculated molecular weight of 13.8 kDa . These differences may result from:

• Post-translational modifications (glycosylation, phosphorylation)

• Protein complexes that resist complete denaturation

• Splice variants or isoforms of the target protein

• Antibody cross-reactivity with related proteins

To address these discrepancies, researchers should:

• Perform mass spectrometry to confirm protein identity

• Use protein prediction tools to identify potential modification sites

• Test multiple antibody clones targeting different epitopes

• Include appropriate negative controls (knockout/knockdown samples)

• Verify with orthogonal methods (immunoprecipitation followed by Western blot)

What approaches can be used to verify antibody specificity in cross-species applications?

Verifying antibody specificity across species requires multiple validation approaches. The YPEL5 antibody described in the search results was validated for reactivity with both human and mouse samples . To ensure cross-species specificity:

• Perform sequence homology analysis between species for the target protein

• Confirm epitope conservation through bioinformatic analysis

• Validate reactivity experimentally in each species using:

  • Western blot with positive and negative controls

  • Immunoprecipitation followed by mass spectrometry

  • Competitive blocking experiments with recombinant proteins

• Test in knockout/knockdown models when available

For immunomonitoring studies like those with YS110 antibody, researchers validated specificity by testing different antibody clones and performing competition and cross-blocking experiments .

What is the recommended protocol for validating antibody specificity when studying proteins with high sequence similarity to other family members?

When studying proteins with high sequence similarity to other family members, such as the YPEL family proteins, a comprehensive validation strategy is essential:

• Epitope mapping: Identify unique epitopes for antibody production. For example, the YPEL5 antibody was raised against a 14 amino acid synthetic peptide near the amino terminus, located within the first 50 amino acids .

• Cross-reactivity testing: Test against recombinant proteins of all family members. The YPEL5 antibody documentation specifically addresses cross-reactivity potential with other family members .

• Knockout/knockdown controls: Use genetic approaches to create negative controls.

• Orthogonal validation: Employ multiple detection methods (e.g., mass spectrometry with immunoprecipitation).

• Computational analysis: Perform sequence alignment of family members to identify unique regions for targeted antibody development.

When properly validated, antibodies can differentiate between closely related proteins. For instance, researchers working with CD26 antibodies developed systematic validation approaches to ensure specificity across assays .

How can researchers overcome epitope masking issues in fixed tissue samples?

Epitope masking is a common challenge when using antibodies in fixed tissues. Based on immunohistochemical approaches mentioned in the search results , several strategies can be implemented:

• Optimize antigen retrieval methods:

  • Heat-induced epitope retrieval (HIER) with various buffers (citrate, EDTA, Tris)

  • Enzymatic retrieval (proteinase K, trypsin)

  • Adjust pH, temperature, and incubation time

• Test different fixation protocols:

  • Compare crosslinking fixatives (formaldehyde) vs. precipitating fixatives (methanol)

  • Reduce fixation time to minimize epitope masking

  • Try post-fixation treatment with glycine to block excess fixative

• Use alternative antibody clones:

  • Test multiple antibodies targeting different epitopes

  • Consider using polyclonal antibodies that recognize multiple epitopes

• Modify blocking and permeabilization:

  • Optimize detergent type and concentration

  • Adjust blocking reagents and incubation times

• Employ signal amplification techniques:

  • Tyramide signal amplification

  • Polymer-based detection systems

What are the best practices for quantifying antibody-based assay results in pharmacodynamic studies?

Quantification of antibody-based assay results in pharmacodynamic studies requires rigorous methodology as demonstrated in the YS110 clinical trial . Best practices include:

• Establish baseline measurements: In the YS110 study, researchers established baseline values for immunophenotyping of peripheral blood lymphocyte CD26+ T and NK cells before treatment .

• Include appropriate controls:

  • Technical controls (isotype controls, FMO controls)

  • Biological controls (healthy donors, pre-treatment samples)

• Standardize assay conditions:

  • Use consistent antibody lots and concentrations

  • Maintain consistent sample processing times

  • Apply standardized gating strategies for flow cytometry

• Account for epitope masking by therapeutic antibodies:

  • The YS110 researchers encountered this issue and validated alternative antibody clones that bind to non-competing epitopes

  • Perform competition and cross-blocking experiments

• Use multiple pharmacodynamic markers:

  • In the YS110 study, researchers monitored:

    • Cell surface marker expression

    • Soluble target levels (sCD26)

    • Enzymatic activity (DPPIV)

    • Cytokine production (IL-6, TNF-α, IL-2)

• Apply appropriate statistical methods:

  • Account for inter-individual variations

  • Use longitudinal analysis for time-course studies

How can researchers differentiate between true binding and non-specific interactions in immunoassays?

Distinguishing true binding from non-specific interactions is crucial for accurate results. Based on antibody validation approaches described in the search results , implement these strategies:

• Perform titration experiments to identify optimal antibody concentration that maximizes signal-to-noise ratio

• Include comprehensive controls:

  • Isotype controls to account for non-specific Fc receptor binding

  • Blocking peptide controls to demonstrate specificity

  • Knockout/knockdown samples as negative controls

• Validate with multiple detection methods:

  • If a signal appears in Western blot, confirm with immunoprecipitation

  • Use mass spectrometry to verify protein identity

• Perform competition assays:

  • Pre-incubate antibody with purified antigen to block specific binding

  • In the YS110 study, researchers used competition and cross-blocking experiments with different antibody clones to verify specificity

• Optimize blocking and washing steps:

  • Test different blocking agents (BSA, casein, serum)

  • Adjust washing buffer composition and duration

• Use secondary validation techniques:

  • Employ orthogonal methods such as proximity ligation assays

  • Consider using multiple antibodies targeting different epitopes

What bioinformatic tools are most effective for predicting antibody epitopes and cross-reactivity?

Based on the epitope prediction work described in the P. falciparum study , several bioinformatic approaches have proven effective:

• Epitope prediction platforms:

  • The iVAX toolkit demonstrated 71% accuracy in predicting HLA-DRB1 allele binding

  • EpiMatrix for epitope density prediction

  • JanusMatrix for assessing potential cross-reactivity with human proteins

• HLA binding prediction tools:

  • NetMHC and NetMHCII for MHC class I and II binding predictions

  • IEDB Analysis Resource suite for epitope analysis

• Protein structure analysis:

  • PyMOL or Chimera for 3D visualization of epitopes

  • ConSurf for evolutionary conservation analysis

• Cross-reactivity assessment:

  • JanusMatrix protein scores can indicate potential for generating undesired autoimmune or regulatory T cell responses

  • BLAST and multiple sequence alignment tools to identify regions of homology

• Metrics for immunogenicity prediction:

  • EpiMatrix protein scores (>20 considered above average for immunogenicity)

  • The P. falciparum study demonstrated that RH5 had an EpiMatrix score of 55.18, higher than several well-known immunogens

When applying these tools, remember that computational predictions should always be validated experimentally, as was done in the P. falciparum study with in vitro HLA binding assays and ex vivo T cell recall assays .

How should researchers interpret contradictory results between different antibody-based assays?

When faced with contradictory results between different antibody-based assays, a systematic troubleshooting approach is necessary:

• Evaluate antibody quality and specificity:

  • Verify antibody validation data for each application

  • Consider lot-to-lot variability

  • Check for proper storage and handling

• Assess technical differences between assays:

  • Native vs. denatured protein conformations

  • Fixation methods affecting epitope accessibility

  • Buffer compositions influencing antibody binding

• Consider biological variables:

  • Post-translational modifications varying between samples

  • Protein complex formation affecting epitope accessibility

  • Splice variants or isoforms recognized differently by antibodies

• Perform orthogonal validation:

  • Use antibody-independent methods (mass spectrometry, PCR)

  • Test multiple antibodies targeting different epitopes

  • Compare monoclonal vs. polyclonal antibodies

• Investigate sample preparation effects:

  • In the YS110 study, researchers found dramatic differences in CD26+ cell detection depending on antibody clone used, demonstrating how therapeutic antibody binding can mask epitopes for detection antibodies

• Document and report all variables:

  • Maintain detailed records of protocols and reagents

  • Report conflicting results transparently in publications

When contradictions arise, they often reveal important biological insights rather than technical failures. For example, the search results mention a contradiction with previous RSC data that required further examination , highlighting how conflicting results can lead to new research directions.